Semaglutide

For Laboratory Research Use Only — Not for Human or Veterinary Use.

Standard (< 1,000 vials)$150/kit

Volume (1,000+ vials)$100/kit

Quantity (kits)

= 10 vials

Minimum order: 100 vials total. Mix and match across all products.

I confirm this order is for laboratory research use only.For Laboratory Research Use Only — Not for Human or Veterinary Use. By checking this box you affirm this product will not be used for human or animal administration.

Specifications

CAS Number	910463-68-2
Molecular Formula	C187H291N45O59
Molecular Weight	4113.58 g/mol
Purity	≥98% (HPLC)
Form	Lyophilized Powder
Storage	-20°C, desiccated, protected from light
Reconstitution	Bacteriostatic water

Certificate of Analysis

Lot documentation

Every production lot is independently third-party tested. A batch-specific Certificate of Analysis — documenting HPLC purity, mass spectrometry identity confirmation, and net peptide content — is issued with every shipment. View a sample COA to see the format.

View Sample COA About our testing →

Research context

Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1 (GLP-1), engineered with amino acid substitutions and a fatty diacid side chain to extend its half-life relative to native GLP-1. In the published literature, it has been studied in vitro and in animal models as a selective agonist of the GLP-1 receptor, a class B G-protein-coupled receptor expressed on pancreatic beta cells and in regions of the central nervous system.

Research into Semaglutide has examined its receptor-binding kinetics, downstream cAMP signaling, and effects on insulin secretion pathways in isolated cell and rodent models. Analytical characterization work has also focused on confirming peptide identity and purity via HPLC and mass spectrometry, and on assessing degradation kinetics under varying storage conditions.

This compound is supplied strictly for in-vitro laboratory research and analytical use. It is not intended for human or veterinary administration, and no statements herein constitute a therapeutic claim or dosing recommendation.